SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Geron Corp.
An SI Board Since November 1996
Posts SubjectMarks Bans Symbol
3576 157 0 GERN
Emcee:  XenaLives Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
3451content.edgar-online.comBenny-Rubin-11/22/2014
3450Shares of Geron Corp.(GERN) rallied 32% to $3.04 on heavy volume after thSavant-11/14/2014
3449Geron Corp.'s stock (GERN) soared 35% in premarket trade MondaSavant-11/3/2014
3448MENLO PARK, Calif., July 24, 2014 /PRNewswire/ -- Asterias Biotherapeutics, Inc.Savant-7/25/2014
3447Thanks for your post. Here's a Seeking Alpha article that has some worthwhilSidney Street-7/1/2014
3446INTRO Here's my semi-annual exercise to see if I remember why I own the stoctktrimbath-6/30/2014
3445Seems this was known a few days ago.....Savant-6/12/2014
3444Partial clinical hold lifted at Mayo Clinic trial Jun 12 2014, 07:05 ET After Sidney Street-6/12/2014
3443The Asterias distribution might be gaining a little more interest. I hope it doSidney Street-5/27/2014
3442 Geron sets May 28, 2014 as the record date for the distribution to GSavant-5/9/2014
3441 Geron 1Q Rev $474,000 1Q Loss $8.44M Sees HiSavant-5/1/2014
3440 Geron Corporation (GERN) Analyst Report: High Potential High Risk Savant-4/7/2014
3439 Geron Reports Myelofibrosis IST Placed on Partial Clinical HoldSavant-3/20/2014
3438 Geron receives verbal notice from the FDA that its IND application fSavant-3/13/2014
3437not good.deeno-3/12/2014
3436 Geron prices 22.5 mln shares of common stock at $4.00 per shareSavant11/31/2014
3435None of those at all. It just all comes natural to me when it comes to stocks. :Benny-Rubin-1/21/2014
3434Then Why is it time to get back in? technical? fundamental? moon is in the 7th hdeeno-1/17/2014
3433I did a Google search but didn't see any resent news.Benny-Rubin-1/17/2014
3432news?deeno-1/17/2014
3431Time to get back in GERN imhoBenny-Rubin-1/17/2014
3430Don't forget about hybrid co w/ BTX that GERN has stock in.Savant-1/1/2014
3429My EOY review of GERN INTRO Here's my semi-annual exercise to see if I remetktrimbath112/31/2013
3428One other thought.... there is something new in the world of FDA's role inscaram(o)uche112/10/2013
3427Investors like round numbers, and biotech investors find them to be particularlyscaram(o)uche-12/10/2013
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News